Remicade (infliximab) - J&J
Stelara (ustekinumab) - J&J
Jyseleca (filgotinib) - Gilead
Entyvio (vedolizumab) - Takeda
http://clinicaltrials.gov/ct2/show/NCT07576452
 
Sep 18, 2026
 
Prev Next